
J&J CEO Duato Urges Tax Fix, Not Tariffs To Drive US Pharma Manufacturing
Johnson & Johnson CEO Joaquin Duato urged President Donald Trump to consider tax policy changes to encourage more U.S. manufacturing of pharmaceuticals—rather than enacting tariffs that could greatly cut into the company’s profits. “If what you want is …